Last reviewed · How we verify
Rohto (r) Hydra
Rohto Hydra is an ophthalmic lubricant that provides moisture and relief to dry eyes by forming a protective hydrating layer on the ocular surface.
Rohto Hydra is an ophthalmic lubricant that provides moisture and relief to dry eyes by forming a protective hydrating layer on the ocular surface. Used for Dry eye syndrome / Dry eye disease.
At a glance
| Generic name | Rohto (r) Hydra |
|---|---|
| Also known as | Rohto Hydra |
| Sponsor | ORA, Inc. |
| Drug class | Ophthalmic lubricant / Artificial tear |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
This over-the-counter eye drop product works as an artificial tear substitute, delivering hydrating agents and lubricants to the cornea and conjunctiva. It helps reduce symptoms of dry eye disease by maintaining tear film stability and protecting the eye surface from further desiccation and irritation.
Approved indications
- Dry eye syndrome / Dry eye disease
Common side effects
- Temporary blurred vision
- Eye irritation
- Allergic reaction (rare)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rohto (r) Hydra CI brief — competitive landscape report
- Rohto (r) Hydra updates RSS · CI watch RSS
- ORA, Inc. portfolio CI